Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.50 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | APP | P05067 | 2/20 | 0.45 |
| ▸ | AGXT | P21549 | 1/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.45 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17666747 | 0.80 | ALDH1A1 (0.34) | CYP2A6ASIC3LOXL2MGLLBCL2L1 | |
| SCHEMBL27745383 | 0.77 | APP (0.49) | CYP2A6ASIC3LOXL2MGLLBCL2L1 | |
| SCHEMBL845603 | 0.76 | APP (0.63) | CYP2A6ASIC3LOXL2MGLLBCL2L1 | |
| SCHEMBL29732980 | 0.76 | APP (0.63) | CYP2A6ASIC3LOXL2MGLLBCL2L1 | |
| SCHEMBL2149703 | 0.73 | APP (0.50) | CYP2A6ASIC3LOXL2MGLLBCL2L1 | |
| SCHEMBL17394561 | 0.72 | AGXT (0.48) | CYP2A6ASIC3LOXL2MGLLBCL2L1 | |
| SCHEMBL6443895 | 0.72 | CYP2A6 (0.48) | CYP2A6ASIC3LOXL2MGLLBCL2L1 | |
| SCHEMBL21322484 | 0.72 | CYP2A6 (0.48) | CYP2A6ASIC3LOXL2MGLLBCL2L1 | |
| SCHEMBL21177766 | 0.72 | CYP2A6 (0.48) | CYP2A6ASIC3LOXL2MGLLBCL2L1 | |
| SCHEMBL6651277 | 0.72 | CYP2A6 (0.48) | CYP2A6ASIC3LOXL2MGLLBCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4482583-B1 | ZWITTERIONIC ANTIBACTERIAL COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2026-04-01 | — | — | EP | disclosed |
| EP-4680677-A1 | BENZOTHIENOPYRROLE CYANINE DYES | Beckman Coulter, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| US-12478621-B2 | Substituted aminoquinolones as dgkalpha inhibitors for immune activation | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2025-11-25 | — | — | US | disclosed |
| US-20250179066-A1 | ZWITTERIONIC ANTIBACTERIAL COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 2025-06-05 | — | — | US | disclosed |
| CN-119661526-A | Perylene imide compound and preparation method and application thereof | 华东理工大学 | 2025-03-21 | — | — | CN | disclosed |
| CN-119564686-A | DGK alpha inhibitors as immune activation substituted aminoquinolones of (2) | 拜耳公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119523983-A | DGK alpha inhibitors as immune activation substituted aminoquinolones of (2) | 拜耳公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119424429-A | DGK alpha inhibitors as immune activation substituted aminoquinolones of (2) | 拜耳公司 | 2025-02-14 | — | — | CN | disclosed |
| WO-2025021855-A1 | MATERIALS FOR ORGANIC LIGHT-EMITTING DEVICES AND ORGANIC SENSORS | MERCK PATENT GMBH (DE) | 2025-01-30 | — | — | WO | disclosed |
| EP-4482583-A1 | ZWITTERIONIC ANTIBACTERIAL COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2025-01-01 | — | — | EP | disclosed |
| CN-1252138-A | Ternary photoinitiator system for curing of epoxy resins | MINNESOTA MINING & MFG (US) | 2000-05-03 | — | — | CN | disclosed |
| CN-1197817-A | Ink jet print head containing radiation curable resin layer | LEXMARK INT INC (US) | 1998-11-04 | — | — | CN | disclosed |
| US-5464865-A | Enzyme inhibitors as antiinflammatory agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1995-11-07 | — | — | US | disclosed |
| EP-0538310-B1 | ETHYNYLBENZOTHIOPHENE PESTICIDES | FMC CORP (US) | 1995-09-13 | — | — | EP | disclosed |
| US-5248686-A | Treatment of nervous depression | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1993-09-28 | — | — | US | disclosed |
| EP-0538310-A4 | ETHYNYLBENZOTHIOPHENE PESTICIDES | — | 1993-07-14 | — | — | EP | disclosed |
| EP-0538310-A1 | ETHYNYLBENZOTHIOPHENE PESTICIDES. | FMC CORP (US) | 1993-04-28 | — | — | EP | disclosed |
| WO-1992000672-A1 | ETHYNYLBENZOTHIOPHENE PESTICIDES | FMC CORPORATION (US) | 1992-01-23 | — | — | WO | disclosed |
| US-5073564-A | Photoactivated insecticides | FMC CORPORATION (US) | 1991-12-17 | — | — | US | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250179066-A1 | ZWITTERIONIC ANTIBACTERIAL COMPOUNDS | MRPL21, WIZ, CFTR | CYP2A6 2634/4885ASIC3 271/4885LOXL2 4587/4885 |
| US-12478621-B2 | Substituted aminoquinolones as dgkalpha inhibitors for immune activation | DGKK, DGKG, DGKA | CYP2A6 2795/4885ASIC3 3800/4885LOXL2 4646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.